NCT06662786 · Interventional trial
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Overall registry status Recruiting
Phase 3
Conditions Colorectal Neoplasms
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory